by McKesson Ventures | Jun 6, 2023 | Media Coverage, Press Releases
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning,...
by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...
by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News
RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...
by McKesson Ventures | Jul 23, 2021 | Media Coverage
While there are more startups than ever, there’s also more money chasing them than ever. Vator News is profiling key members of the investment community to help companies understand what investors are looking for and how they can help startups to scale. In this...
by McKesson Ventures | Jul 12, 2021 | Media Coverage
In a recent episode of the Virtual Care Paradigm, McKesson Ventures Partner Michelle Snyder discussed how a virtual-first approach to healthcare could become the new norm. Snyder started off by discussing the growing interest in investing in primary care. “I remember...
by McKesson Ventures | Jun 28, 2021 | Media Coverage
McKesson Ventures Partner Michelle Snyder was one of the speakers at a recent HLTH webinar on investment trends in the health tech field. The webinar, held June 24, 2021, also featured Keith Figloli, general partner at LVRHealth; and Anne Wellington, managing director...
